KCNMA1 and Parkinson disease: Whilst the inhibitors used in the present study have not yet been tested in the context of neurodegeneration in PD, AMG44 treatment relieved ER stress and normalized BK channel physiology in the cellular model of multiple sclerosis [32], and JNK V was effective at reducing the negative effects of stroke in gerbils [33].